SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Nutra Pharma Corp. (NPHC) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 15/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — NPHC
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2013 |
$-0.23 |
$122.2K |
$-4.34M |
-3554% |
| 2014 |
$-0.08 |
$594.51K |
$-2.53M |
-426.1% |
| 2015 |
$-0.10 |
$291.3K |
$-5.39M |
-1851% |
| 2016 |
$-0.02 |
$168.36K |
$-3.45M |
-2047.8% |
| 2017 |
$0.00 |
$120.98K |
$-4.03M |
-3330.1% |
| 2018 |
$0.00 |
$130.6K |
$-3.88M |
-2974.6% |
| 2019 |
$0.00 |
$104.39K |
$-1.66M |
-1591.4% |
| 2020 |
$0.00 |
$51.9K |
$-769.18K |
-1482.1% |
| 2021 |
$0.00 |
$97.74K |
$-3.47M |
-3546% |
| 2022 |
$0.00 |
$0.00 |
$0.00 |
- |
